Imitrex "Authorized" Generic Launch Planned In Q4 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline and Dr. Reddy's reach settlement agreement on the migraine tablets allowing a generic launch several months prior to patent expiration.
You may also be interested in...
Dr Reddy’s Launches Generic Versions Of GSK’s Imitrex; Ranbaxy May Have To Wait
MUMBAI - One more blockbuster drug will be available to U.S. citizens at a fraction of its brand price as India's Dr Reddy's announced the launch of generic versions of GlaxoSmithKline's anti-migraine drug Imitrex (sumatriptan)
Latest Imitrex Patent Settlement Protects GSK’s “Authorized” Generic
Dr. Reddy’s sumatriptan generic will likely hit the market several months before Cobalt’s launches in 2009.
Latest Imitrex Patent Settlement Protects GSK’s “Authorized” Generic
Dr. Reddy’s sumatriptan generic will likely hit the market several months before Cobalt’s launches in 2009.